Store
GS2/3 · Health regulation

NDCT Rules amendment: test licences move to intimation

1 min readGovernanceHealth
Battle IAS current affairs title card: NDCT Rules amendment: test licences move to intimation (GS2/3 · Health regulation, 3 September 2025)

What happened

  • The Health Ministry published draft amendments to the New Drugs and Clinical Trials Rules, 2019 on 28 August 2025 for comments [PIB].
  • Test licences would move from a licence system to notification/intimation, except for a small high-risk category; BA/BE study applications would be simplified [PIB].

Background

  • The aim is to cut compliance and help pharma and clinical research [PIB].

Why it matters

  • Speed helps research, but the high-risk carve-out is where safety concerns stay.

How to use this in Mains

GS-II Issues relating to development and management of health

  1. As per PIB (2025-09-03): the Health Ministry published draft amendments to the New Drugs and Clinical Trials Rules, 2019 on 28 August 2025 for comments.
  2. Speed helps research, but the high-risk carve-out is where safety concerns stay.
Quotable data point

The Health Ministry published draft amendments to the New Drugs and Clinical Trials Rules, 2019 on 28 August 2025 for comments.

PIB: NDCT Rules amendment, 3 Sep 2025

Exam angle

UPSC

Prelims: NDCT Rules 2019.

Practice MCQs

Original practice questions (not PYQs).

Practice · UPSC

Year of the New Drugs and Clinical Trials Rules

Answer (b) & explanation

PIB.

Go deeper

ExplainerNational Sports Governance Act, 2025: National Sports Board, National Sports Tribunal, Rules for Sports Federations, Athletes’ Voice, BCCI Question and Sports Policy (UPSC Notes + PYQs)ExplainerCentral Pay Commissions in India: From the 1st to the 8th CPC, Terms of Reference, Fitment Factor, Pay Matrix, Fiscal Impact and Reform Debates (UPSC Notes + PYQs)

Official source: PIB: NDCT Rules amendment, 3 Sep 2025

facts from cited sources only; faculty review pending